Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Clinical trial NCT04774952 · COMPLETED
Trial details
- NCT number
- NCT04774952
- Sponsor
- Revolution Medicines, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-07
- Primary completion
- 2024-05-06
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.